By Heo Ji-yoon – Chosun Biz –
Korean patients gain access to innovative regenerative medical treatments after law changes.
Next month, patients with severe, rare, and incurable diseases such as arthritis, autoimmune diseases, Parkinson’s disease, and cancer will be able to receive stem cell and immune cell therapies currently in the development stage.
Until now, patients in South Korea were unable to use developing cell and gene therapies except to participate in clinical research due to regulations. Consequently, many patients traveled to Japan for treatment, but the law will be amended and come into effect next month.
